FARSLB (FARSB) (NM_005687) Human Tagged ORF Clone Lentiviral Particle
CAT#: RC204639L1V
- LentiORF®
-
Lenti ORF particles, FARSB (Myc-DDK tagged) - Human phenylalanyl-tRNA synthetase, beta subunit (FARSB), 200ul, >10^7 TU/mL
Need custom lentivirus service?
Get a free quote
CNY 8,930.00
Product images
![](https://cdn.origene.com/img/defaults-img.jpg)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | FARSLB (FARSB) (NM_005687) Human Tagged ORF Clone Lentiviral Particle |
Synonyms | FARSLB; FRSB; HSPC173; NEDBLLA; PheHB; PheRS; RILDBC; RILDBC1 |
Vector | pLenti-C-Myc-DDK |
ACCN | NM_005687 |
ORF Size | 1767 bp |
Sequence Data |
The ORF insert of this clone is exactly the same as(RC204639).
|
OTI Disclaimer | The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info |
OTI Annotation | This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. |
Reference Data | |
RefSeq | NM_005687.3 |
RefSeq Size | 2233 bp |
RefSeq ORF | 1770 bp |
Locus ID | 10056 |
Domains | B3_4, B5 |
Protein Pathways | Aminoacyl-tRNA biosynthesis |
MW | 66.1 kDa |
Gene Summary | This gene encodes a highly conserved enzyme that belongs to the aminoacyl-tRNA synthetase class IIc subfamily. This enzyme comprises the regulatory beta subunits that form a tetramer with two catalytic alpha subunits. In the presence of ATP, this tetramer is responsible for attaching L-phenylalanine to the terminal adenosine of the appropriate tRNA. A pseudogene located on chromosome 10 has been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015] |
Documents
Product Manuals |
FAQs |
SDS |